Quantitative assessment of human serum transferrin receptor in breast cancer patients pre- and post-chemotherapy using peptide immunoaffinity enrichment coupled with targeted proteomics

SISCAPA-targeted proteomics may allow the quantification of low-abundant proteins in a more accurate manner.